Xconomy

MAY 31, 2017

Challenging work, ongoing training, an opportunity to advance without having to become a manager, and a talented peer group all help companies recruit and retain these sought-after “ninjas”—the individuals who can do what artificial intelligence security tools can’t.

Artificial Inteligence 73

Artificial Inteligence Company Companies Training 73

Xconomy

SEPTEMBER 23, 2019

Ivan Liachko turned postdoctoral research at the University of Washington into a company whose genomics tools are now found in laboratories researching human, animal, and plant health. But as a CEO of a growing company, Liachko now sees missed opportunities for UW and the Puget Sound region.

Incubator 111

Incubator Research Tool Startup 111

socalTECH

APRIL 13, 2012

Demonstrating in dramatic fashion why BlackBerry maker Research in Motion seems to be in so much trouble these days, Irvine-based YouMail , which develops personalized voicemail services and related applications, said it is saying goodbyte to the BlackBerry platform. READ MORE>>.

Blogging 154

Blogging Research Platform Services 154

Xconomy

SEPTEMBER 2, 2020

Lumen CEO Brian Finrow (pictured above, right) acknowledges spirulina’s health benefits, but that’s not why his company embraces it. Research has yielded a crop of gastrointestinal disorder drug. Seattle-based Lumen turns spirulina into tiny factories that churn out therapeutic antibodies.

Research 120

Research Startup Technology San Diego 120

Xconomy

APRIL 14, 2020

Pharmaceutical giants GlaxoSmithKline and Sanofi are teaming up on COVID-19 research, aiming to combine their respective technologies in a new vaccine that could start clinical trials in coming months. The full details of the agreement, which was announced Tuesday, are still being finalized.

Research 126

Research Startup Technology San Diego 126

InfoChachkie

DECEMBER 15, 2011

A Little Research Goes a Long Way. It turned out that he was looking for companies he could work with as a consultant. If he had spent any time reading my blog, he would have understood that I am not a fan of consultants , especially at startups. Research? – If you haven't already subscribed yet, subscribe now for.

Networking 231

Networking Blogging Santa Barbara Startup 231

socalTECH

DECEMBER 27, 2017

This means organizations will require new and different external research to understand what tools they must provide in order to help their members make progress. Research Keeps Associations Connected to Member Problems that Need to Be Solved. Their research identified four segments in their marketplace.

Research 140

Research Organization Help Product 140

Xconomy

MAY 6, 2019

The La Jolla-CA-based company, spun out of research from The Scripps Research Institute (TSRI), is developing drugs to treat diseases of the central nervous system, among them Tourette syndrome. Lundbeck could pay Abide shareholders up to another $150 million if the company’s drugs hit certain development and sales.

Research 98

Research Sales Develop Development 98

Xconomy

APRIL 7, 2020

The Plymouth Meeting, PA-based company, which also conducts research in San Diego, plans to enroll as many as 40 adults across two trial locations. The trials are taking place at the University of Pennsylvania’s Perelman School of Medicine in Philadelphia and at the Center for Pharmaceutical Research in Kansas City, MO.

San Diego 108

San Diego Study Research Develop 108

InfoChachkie

JUNE 9, 2014

If he had spent any time reading my blog, he would have learned that I am not a fan of consultants, especially at startups. Research? – I do not expect everyone I speak with to be a fan of my humble blog. – I do not expect everyone I speak with to be a fan of my humble blog. Are there any companies I should contact?".

Networking 232

Networking Santa Barbara Research Blogging 232

Xconomy

APRIL 10, 2020

The coronavirus research is expected. Two biotech companies have gone public in the past week; each upsized its offering and saw a healthy IPO pop. The COVID-19 pandemic has stopped enrollment in many clinical trials and postponed the start of others but there is still life in the life sciences sector.

Activity 103

Activity Research Invest Startup 103

From the Venture Trenches

APRIL 19, 2013

This was in direct response to the implosion of the tech bubble and the fall out of Enron, Worldcom and the questionable research produced by the investment banks in general and Blodget in particular. In 2003 Blodget struck a civil settlement deal with the SEC that cost him $4 million. Blodget also agreed never to work on the Street again.

Blogging 45

Blogging News Journal Invest 45

Xconomy

JANUARY 22, 2019

LunaDNA, a startup that is offering individuals company stock in exchange for personal genomic and health information in a bid to build a database that could help advance scientific research, is merging its research platform with the Genetic Alliance’s Platform for Engaging Everyone Responsibly (PEER). LunaPBC, a public-benefit.

Platform 110

Platform Research Organization Help 110

Xconomy

MAY 21, 2019

These days, Thrun seems just as excited by another imprint he’s made on the still-forming AV industry—not as a researcher, but as an entrepreneur in online education. Read more » Reprints | Share: UNDERWRITERS AND PARTNERS.

Education 87

Education Software Engineering Training Research 87

Both Sides of the Table

MAY 6, 2015

To mark the occasion of launching this inaugural report I am also proud to announce that we’ve also launched the Upfront Insights blog. We intend to put out more research both on our geography but also on the markets we’re interested in investing in.

Marketing 150

Marketing Newsletter Venture Capital Blogging 150

Xconomy

APRIL 22, 2020

Drug research aiming to turn bacteria into microbiome therapies now spans programs aiming to address gut disorders, autism, cancer, and more. Positive results could help win over large pharmaceutical companies and investors who have doubted microbiome therapies. “In In every new (drug) class there’s always been people.

Class 138

Class Study Research Report 138

Both Sides of the Table

JANUARY 26, 2013

One of the advantages of blogging, using social media, public speaking, etc as a VC is that you get a more nuanced view of these shifts by watching your own successes and failures. But succinctly this press places a marker in the ground for your company. But in 2013 it can also simply be, “Company X raises $2.2

Startup 355

Startup Funding News Press 355

Startup Professionals Musings

NOVEMBER 27, 2021

I still remember my disappointment the first time I published my website, did an immediate Google search on the name, and it said my company didn’t exist. I’ve said many times that the Internet domain name should be reserved at the same time you incorporate your company name – they need to be the same, or highly related.

Web 139

Web Startup Sites Design 139

From the Venture Trenches

APRIL 19, 2013

This was in direct response to the implosion of the tech bubble and the fall out of Enron, Worldcom and the questionable research produced by the investment banks in general and Blodget in particular. In 2003 Blodget struck a civil settlement deal with the SEC that cost him $4 million. Blodget also agreed never to work on the Street again.

Blogging 40

Blogging News Journal Invest 40

Southern California Edison Blog

JANUARY 15, 2019

You can’t always do all three with your current resources, which is why many carriers partner with telecom infrastructure companies. Telecom infrastructure companies can fill the gaps in your own capabilities so you can achieve key growth initiatives. Wireless Backhaul. Wireless Infrastructure.

SoCal 55

SoCal Southern California Help Services 55

Startup Professionals Musings

SEPTEMBER 16, 2022

Getting a fixed price bid works for well-defined short-term projects, like blogging or programming. Do your research with peers, and check the alternatives on every project. Some entrepreneurs view their outsourced employees as temps, or as a cheap way to staff the company during its startup phase. Be flexible.

Outsource Development 138

Outsource Development Outsource Summary Training 138

Xconomy

SEPTEMBER 30, 2020

That research is starting to pay off as the companies now look ahead to pivotal studies testing that compound in several inherited forms of the disorder. Ovid Therapeutics and Takeda Pharmaceutical joined forces three years ago to develop a small molecule into a potential epilepsy drug.

Statistics 111

Statistics Study Report Research 111

Both Sides of the Table

JANUARY 23, 2011

Obviously you should have somebody that helps you research journalists, gets you meetings, pitches stories, helps prep you for interviews & helps make sure your writing is cogent. But some CEOs then try to have more junior people in the company take the interview. That’s why keeping a personal blog is so great.

Startup 349

Startup Writing Press Blogging 349

Xconomy

AUGUST 11, 2020

Ligand Pharmaceuticals plans to acquire recombinant protein therapeutics maker Pfenex for $438 million, the companies announced Monday. The larger company agreed to pay $12 per share for Pfenex (NYSE American: PFNX )—a 57 percent premium to its closing price Monday. The company reported revenues of about $120.3

San Diego 98

San Diego Technology Research Pricing 98

Xconomy

APRIL 29, 2019

In 2005, Japan’s big drug firm Takeda acquired a company in North America for the first time. That company was Syrrx, a private San Diego-based biotech that used X-ray crystallography to help determine the structures of disease-related molecules so drugs could be designed to target them. More than 90 percent of them are researchers.

San Diego 89

San Diego Research Design Acquisition 89

Xconomy

MAY 15, 2017

San Diego’s Scientist.com set out in 2006 to disrupt part of the pharmaceutical business by providing an Amazon-like approach to the business of hiring contract research organizations (CROs). Founding CEO Kevin Lustig said Scientist.com will use the additional cash to expand its operations. Lustig argued.

Outsource 79

Outsource Marketing Research Web 79

Xconomy

APRIL 16, 2019

Now the company has its first pharmaceutical partner. Insitro announced Tuesday that Gilead (NASDAQ: GILD ) will pay the South San Francisco-based startup $15 million to kick off a three-year research collaboration. The deal calls for Insitro to create disease models for NASH in hopes of finding targets.

Artificial Inteligence 100

Artificial Inteligence Research Startup Company 100

Xconomy

NOVEMBER 11, 2019

These are heady times for neuroscience research. What’s Next in Neuroscience Therapies will take a look at new technologies that are changing how we understand brain diseases and spinal injuries, as well as novel approaches that companies are taking to treat these conditions. One failed drug neuro drug is getting another shot.

Research 83

Research Startup Technology Develop 83

Xconomy

AUGUST 7, 2019

In the meantime, the company built a business as a contract research organization around its 3-D human tissue cultures, which pharma companies have used. Read more » Reprints | Share: UNDERWRITERS AND PARTNERS.

San Diego 90

San Diego Outsource Development Organization Research 90

Xconomy

APRIL 30, 2019

Vividion Therapeutics, a biotechnology company that launched in 2017 around discoveries made in Scripps Research Institute labs, has raised $82 million in financing. Nextech Invest, a Swiss investment firm that funds companies developing cancer therapeutics, led the Series B round of funding.

Research 87

Research Invest Funding Develop 87

Xconomy

JUNE 26, 2020

Once considered all but shuttered, the IPO market again saw an active week between new public debuts and more companies joining the queue. IPO research firm Renaissance Capital says it anticipates—what else—a “renaissance” in the public markets come third quarter.

News 104

News Activity Research Marketing 104

Xconomy

JUNE 19, 2017

The San Diego biotech company Synthetic Genomics and supermajor ExxonMobil (NYSE: XOM ) said today they have successfully inserted a gene in a particular strain of algae that more than doubled its oil content without slowing down the algae’s rate of growth. See below. ] Read more » Reprints | Share: UNDERWRITERS AND PARTNERS.

San Diego 103

San Diego Press Research Conference 103

Eric Greenspan

MAY 7, 2013

My company Zodiac805 was contracted to build this list. After an exhaustive search, we’ve compiled an amazing list that has already been proven by the company that hired us. About me: I’m a dad, a social research marketer, customer service champion, closet chef, TEDster. About my company: [link].

IBM 154

IBM IBM Email Research 154

Xconomy

JANUARY 27, 2020

So far this year four privately held companies have made the transition to trading on the public markets. By month’s end, five more are anticipated to join the class of 2020 initial public offerings—and four of those are in life sciences, according to IPO research firm Renaissance Capital.

Westlake Village 109

Westlake Village Class Research Capital 109

Xconomy

JUNE 20, 2019

So far this year, 72 companies have gone public, according to IPO research firm Renaissance Capital. But healthcare IPOs continue to lead the pack, with 33 companies going public—the most of any sector. That total is down 20 percent compared to the same period a year ago.

Research 108

Research Activity Capital Marketing 108

Xconomy

MAY 9, 2019

It will be hard to top last year’s flurry of biotech companies joining the public markets, but this week is shaping up to be the busiest for life science IPOs in recent memory. According to IPO research firm Renaissance Capital , 47 IPOs have priced so far this year across all sectors, down 27 percent compared to the same period in 2018.

Pricing 110

Pricing Research Capital Marketing 110

Xconomy

SEPTEMBER 11, 2020

COVID-19 research efforts are often described as a race between companies, a description that reflects the urgency to develop a vaccine for the novel coronavirus. Still, politicians have pressed companies to move even faster. Nine companies signed a. The description is not quite right.

Press 76

Press Research Develop Development 76